Abbott Settles the $495 Million NEC Verdict: Gill Appeal Ends on Confidential Terms

How the biggest NEC verdict ended

The Gill case has anchored the plaintiff side of the NEC ledger for two years. In July 2024, a St. Louis jury found that Abbott failed to warn about the alleged risk of necrotizing enterocolitis from its cow's-milk-based Similac preterm formula and awarded $495 million, $95 million in compensatory damages and $400 million in punitive damages, to the family of an Illinois girl who developed the disease as a premature infant. It was, and remains, the largest verdict in the litigation.

Abbott appealed and lost twice. Missouri's Court of Appeals affirmed the judgment on May 5, 2026, though in an unpublished opinion that carries no precedential weight, and on June 22, 2026 it declined to transfer the case to the state's highest court. That left Abbott applying directly to the Missouri Supreme Court, a discretionary long shot but one with real stakes: a reversal would have erased the verdict, while a published affirmance could have hardened Missouri law against the company across the rest of the state docket. The August 17 settlement takes both outcomes off the table. Neither side has disclosed the terms, and neither company spokespeople nor the family's attorneys commented on the agreement.

Why settle a verdict you are still appealing?

A settlement at this stage is best read as both sides buying certainty. For the family, it converts a verdict that could still have been reduced or overturned into an agreed payment now. For Abbott, it caps the exposure on a $495 million judgment accruing post-judgment interest, and it avoids the risk that Missouri's highest court would issue a published, precedential opinion affirming a punitive award of that size in the state where much of the NEC state-court litigation sits. Companies also sometimes prefer a confidential number to a public one that plaintiffs' counsel can wave at the next jury.

What the settlement does not do is resolve the underlying scientific dispute. Abbott and Mead Johnson maintain that their preterm formulas do not cause NEC, that human milk's protective benefits rather than formula exposure explain the association, and that specialty formulas are part of the standard of care when human milk is unavailable. The federal courts have largely credited the defense on causation so far: the first three MDL bellwethers were dismissed on summary judgment, the Seventh Circuit affirmed one of those dismissals in Mar v. Abbott on July 24, 2026, and a published Illinois opinion reversed the $60 million Watson verdict on learned intermediary grounds in June. A one-case settlement changes none of that law.

What it means for the 825 pending MDL cases

Directly, nothing. MDL-3026, before Judge Rebecca Pallmeyer in the Northern District of Illinois, had 825 pending actions as of the August 1, 2026 JPML report, and those cases proceed on their own tracks, as do the state-court inventories in Illinois, Missouri, and Pennsylvania. No global settlement or settlement program exists, none has been announced, and the confidential Gill terms are not a guide to what any other claim is worth. Verdicts in this litigation have ranged from $495 million to zero, several have been reversed or vacated, and the federal bellwethers have not reached a jury at all.

Indirectly, the settlement is still a data point. Abbott has now paid something, in an undisclosed amount, to resolve a tried NEC case rather than litigate it to the end, which is a different posture than defending every case to final judgment. Whether that translates into broader resolution talks depends on variables nobody outside the negotiating rooms can see, including the fate of the $70 million Cook County verdict now in post-trial proceedings and the Watson retrial. Predicting a global settlement from one confidential deal would be irresponsible, and we are not doing it.

This is general litigation reporting and not legal advice. Filing deadlines for a child's claim vary by state, are often tolled during minority, and can bar a claim regardless of its merits. Families weighing a claim should speak with a licensed attorney about their own situation.